您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Tizanidine-d4(hydrochloride)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Tizanidine-d4(hydrochloride)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Tizanidine-d4(hydrochloride)图片
规格:98%
分子量:294.2
包装与价格:
包装价格(元)
500ug电议
1mg电议

产品介绍
An internal standard for the quantification of tizanidine
货号:ajcx23620
CAS:1188263-51-5
分子式:C9H4ClD4N5S.HCl
分子量:294.2
溶解度:Methanol: soluble,Water: soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Tizanidine-d4is intended for use as an internal standard for the quantification of tizanidine by GC- or LC-MS. Tizanidine is an α2-adrenergic receptor (α2-AR) agonist.1Administration of tizanidine reduces neuronal excitation induced by noxious stimuli and depresses spontaneous neuronal firing in anesthetized cats. Tizanidine-induced neuronal depression is reversed by the selective α2-AR antagonist RX781094 but not the α1-AR antagonists prazosin and WB-4101. It acts as a muscle relaxant that inhibits α- and γ-rigidity in rats, reflex muscle tone in rabbits, and the linguomadibular reflex in cats without sedative, hemodynamic, or neurochemical effects.2Formulations containing tizanidine have been used for the treatment of stiff-person syndrome and to improve gait function in patients with incomplete spinal cord injuries.3,4


1.Davies, J., and Quinlan, J.E.Selective inhibition of responses of feline dorsal horn neurons to noxious cutaneous stimuli by tizanidine (DS103-282) and noradrenaline: Involvement of α2-adrenoceptorsNeuroscience16(3)673-682(1985) 2.Sayers, A.C., BÜrki, H.R., and Eichenberger, E.The pharmacology of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (DS 103-282), a novel myotonolytic agentArzneimittelforschung30(5)793-803(1980) 3.Meinck, H.-M., Ricker, K., and Conrad, B.The stiff-man syndrome: New pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidineJ. Neurol. Neurosurg. Psychiatry47(3)280-287(1984) 4.Duffell, L.D., Brown, G.L., and Mirbagheri, M.M.Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injuryJ. Neuroeng. Rehabil.1229(2015)